{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T20:02:18Z","timestamp":1787256138569,"version":"build-2736575974"},"reference-count":56,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"14","license":[{"start":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T00:00:00Z","timestamp":1699833600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,7,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Non-alcoholic fatty liver disease (NAFLD) and inflammatory bowel disease (IBD) have shown similar worsening epidemic patterns globally and shared various overlapping pathophysiological mechanisms. However, evidence on the relationship between NAFLD and IBD risk is lacking. We aimed to investigate the associations between long-term risk of incident IBD and NAFLD in a large prospective cohort.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Participants from the United Kingdom Biobank cohort (https:\/\/biobank.ndph.ox.ac.uk\/) who were free of IBD and alcoholic liver disease at baseline were enrolled. Baseline non-alcoholic fatty liver degree was measured by the well-established fatty liver index (FLI). The outcomes of interest included incident IBD, ulcerative colitis (UC), and Crohn's disease (CD). Multivariable Cox proportional hazard regression was used to calculate hazard ratios (HRs) and 95% confidence intervals (CIs).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Among 418,721 participants (mean FLI: 48.11 \u00b1 30.11), 160,807 (38.40%) participants were diagnosed as NAFLD at baseline. During a median of 12.4 years' follow-up, 2346 incident IBD cases (1545 UC, 653 CD, and 148 IBD-unclassified) were identified. Due to limited events, those IBD-unclassified were combined in UC or CD when examining the associated risk of UC or CD, separately. Compared with the lowest quartile of FLI, the highest quartile showed a separately 36.00%, 25.00%, and 58.00% higher risk of incident IBD (HR<jats:sub>Q4 <\/jats:sub>\n                                 <jats:italic toggle=\"yes\">\n                                    vs.\n                                 <\/jats:italic>\n                                 <jats:sub>Q1<\/jats:sub> = 1.36, 95% CI: 1.19\u20131.55, <jats:italic toggle=\"yes\">P<\/jats:italic>\n                                 <jats:sub>trend<\/jats:sub>&lt;0.001), UC (HR<jats:sub>Q4 <\/jats:sub>\n                                 <jats:italic toggle=\"yes\">\n                                    vs.\n                                 <\/jats:italic>\n                                 <jats:sub>Q1<\/jats:sub> = 1.25, 95% CI: 1.07\u20131.46, <jats:italic toggle=\"yes\">P<\/jats:italic>\n                                 <jats:sub>trend<\/jats:sub> = 0.047), and CD (HR<jats:sub>Q4 <\/jats:sub>\n                                 <jats:italic toggle=\"yes\">\n                                    vs.\n                                 <\/jats:italic>\n                                 <jats:sub>Q1<\/jats:sub> = 1.58, 95% CI: 1.26\u20131.97, <jats:italic toggle=\"yes\">P<\/jats:italic>\n                                 <jats:sub>trend<\/jats:sub> &lt;0.001) after multivariable adjustment. Compared with non-NAFLD, NAFLD participants had a significantly higher risk of incident IBD (HR = 1.13, 95% CI: 1.04\u20131.24) and CD (HR = 1.36, 95% CI: 1.17\u20131.58).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Higher degree of non-alcoholic fatty liver is associated with increased risk of incident IBD. Interventions aimed at improving NAFLD may be a potential targeted strategy for the detection and treatment of IBD.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/cm9.0000000000002859","type":"journal-article","created":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T13:07:21Z","timestamp":1699967241000},"page":"1705-1714","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["Non-alcoholic fatty liver degree and long-term risk of incident inflammatory bowel disease: A large-scale prospective cohort study"],"prefix":"10.1097","volume":"137","author":[{"given":"Qian","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengtao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongdong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shutian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,11,13]]},"reference":[{"key":"R1-20250602","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: A systematic review of population-based studies","volume":"390","author":"Ng","year":"2017","journal-title":"Lancet"},{"key":"R2-20250602","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nrgastro.2015.34","article-title":"Epidemiology and risk factors for IBD","volume":"12","author":"Ananthakrishnan","year":"2015","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R3-20250602","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/j.1572-0241.2001.03756.x","article-title":"The prevalence of extraintestinal diseases in inflammatory bowel disease: A population-based study","volume":"96","author":"Bernstein","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"R4-20250602","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/ibd\/izac096","article-title":"Inflammatory bowel disease and long-term risk of cancer: A prospective cohort study among half a million adults in UK Biobank","volume":"29","author":"Wu","year":"2023","journal-title":"Inflamm Bowel Dis"},{"key":"R5-20250602","doi-asserted-by":"crossref","first-page":"765474","DOI":"10.3389\/fmed.2021.765474","article-title":"Treatment of inflammatory bowel disease: A comprehensive review","volume":"8","author":"Cai","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"R6-20250602","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1136\/gutjnl-2020-322308","article-title":"Depression in individuals who subsequently develop inflammatory bowel disease: A population-based nested case\u2013control study","volume":"70","author":"Blackwell","year":"2021","journal-title":"Gut"},{"key":"R7-20250602","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1136\/gutjnl-2020-320789","article-title":"Inflammatory bowel disease is associated with higher dementia risk: A nationwide longitudinal study","volume":"70","author":"Zhang","year":"2020","journal-title":"Gut"},{"key":"R8-20250602","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1093\/ecco-jcc\/jjab212","article-title":"Inflammatory bowel disease-associated fatty liver disease: The potential effect of biologic agents","volume":"16","author":"Papaefthymiou","year":"2022","journal-title":"J Crohns Colitis"},{"key":"R9-20250602","doi-asserted-by":"crossref","first-page":"9139","DOI":"10.3390\/ijms22179139","article-title":"Molecular and pathophysiological links between metabolic disorders and inflammatory bowel diseases","volume":"22","author":"Hyun","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R10-20250602","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"key":"R11-20250602","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S2468-1253(19)30333-4","article-title":"The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990\u20132017: A systematic analysis for the Global Burden of Disease Study 2017","volume":"5","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R12-20250602","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nrgastro.2016.181","article-title":"Obesity in IBD: Epidemiology, pathogenesis, disease course and treatment outcomes","volume":"14","author":"Singh","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R13-20250602","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease: Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"R14-20250602","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: Trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R15-20250602","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMra011775","article-title":"Nonalcoholic fatty liver disease","volume":"346","author":"Augulo","year":"2002","journal-title":"N Engl J Med"},{"key":"R16-20250602","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.2337\/diabetes.50.8.1844","article-title":"Nonalcoholic fatty liver disease: A feature of the metabolic syndrome","volume":"50","author":"Marchesini","year":"2001","journal-title":"Diabetes"},{"key":"R17-20250602","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/apt.12794","article-title":"Systematic review: The epidemiology of the hepatobiliary manifestations in patients with inflammatory bowel disease","volume":"40","author":"Gizard","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"R18-20250602","doi-asserted-by":"crossref","first-page":"7528","DOI":"10.3748\/wjg.v26.i47.7528","article-title":"Prevalence and associated factors of obesity in inflammatory bowel disease: A case-control study","volume":"26","author":"Losurdo","year":"2020","journal-title":"World J Gastroenterol"},{"key":"R19-20250602","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.4254\/wjh.v13.i12.1956","article-title":"Liver manifestations and complications in inflammatory bowel disease: A review","volume":"13","author":"Gaspar","year":"2021","journal-title":"World J Hepatol"},{"key":"R20-20250602","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1093\/ibd\/izab199","article-title":"The impact of NAFLD on hospitalization outcomes in patients with inflammatory bowel diseases: Nationwide analysis","volume":"28","author":"Noorian","year":"2022","journal-title":"Inflamm Bowel Dis"},{"key":"R21-20250602","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001779","article-title":"UK biobank: An open access resource for identifying the causes of a wide range of complex diseases of middle and old age","volume":"12","author":"Sudlow","year":"2015","journal-title":"PLoS Med"},{"key":"R22-20250602","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-230X-6-33","article-title":"The fatty liver index: A simple and accurate predictor of hepatic steatosis in the general population","volume":"6","author":"Bedogni","year":"2006","journal-title":"BMC Gastroenterol"},{"key":"R23-20250602","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.clnu.2019.02.024","article-title":"Fatty liver index (FLI) and prediction of new cases of non-alcoholic fatty liver disease: A population-based study of northern Iran","volume":"39","author":"Motamed","year":"2020","journal-title":"Clin Nutr"},{"key":"R24-20250602","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.cgh.2012.12.031","article-title":"External validation of the fatty liver index for identifying nonalcoholic fatty liver disease in a population-based study","volume":"11","author":"Koehler","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R25-20250602","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.dld.2009.08.002","article-title":"Hepatic steatosis index: A simple screening tool reflecting nonalcoholic fatty liver disease","volume":"42","author":"Lee","year":"2010","journal-title":"Dig Liver Dis"},{"key":"R26-20250602","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s42000-022-00377-8","article-title":"Non-invasive diagnosis and staging of non-alcoholic fatty liver disease","volume":"21","author":"Kechagias","year":"2022","journal-title":"Hormones (Athens)"},{"key":"R27-20250602","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1007\/s40618-021-01501-y","article-title":"Prevalence of hepatic steatosis in patients with type 2 diabetes and response to glucose-lowering treatments. A multicenter retrospective study in Italian specialist care","volume":"44","author":"Morieri","year":"2021","journal-title":"J Endocrinol Invest"},{"key":"R29-20250602","doi-asserted-by":"crossref","first-page":"27952","DOI":"10.1074\/jbc.M109.046292","article-title":"AMP-activated protein kinase mediates the interferon-gamma-induced decrease in intestinal epithelial barrier function","volume":"284","author":"Scharl","year":"2009","journal-title":"J Biol Chem"},{"key":"R30-20250602","first-page":"136","article-title":"Expression of intestinal tight junction proteins in patients with non-alcoholic fatty liver disease","volume":"61","author":"Xin","year":"2014","journal-title":"Hepatogastroenterology"},{"key":"R31-20250602","doi-asserted-by":"crossref","first-page":"678355","DOI":"10.3389\/fimmu.2021.678355","article-title":"The alterations in and the role of the Th17\/Treg balance in metabolic diseases","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Immunol"},{"key":"R32-20250602","doi-asserted-by":"crossref","first-page":"6242","DOI":"10.3390\/ijms22126242","article-title":"Interaction between lipopolysaccharide and gut microbiota in inflammatory bowel diseases","volume":"22","author":"Candelli","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R33-20250602","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.3390\/ijms21093379","article-title":"Interplay between cytokine circuitry and transcriptional regulation shaping helper T cell pathogenicity and plasticity in inflammatory bowel disease","volume":"21","author":"Fu","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R34-20250602","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1097\/MIB.0000000000000210","article-title":"Comprehensive intestinal T helper cell profiling reveals specific accumulation of IFN-\u03b3+IL-17+coproducing CD4+ T cells in active inflammatory bowel disease","volume":"20","author":"Globig","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"R35-20250602","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/hep.28572","article-title":"Gut microbiota profiling of pediatric nonalcoholic fatty liver disease and obese patients unveiled by an integrated meta-omics-based approach","volume":"65","author":"Del Chierico","year":"2017","journal-title":"Hepatology"},{"key":"R36-20250602","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3389\/fmed.2018.00304","article-title":"Disease-specific enteric microbiome dysbiosis in inflammatory bowel disease","volume":"5","author":"Mirsepasi-Lauridsen","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"R37-20250602","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.3390\/nu12051434","article-title":"Connecting the dots between inflammatory bowel disease and metabolic syndrome: A focus on gut-derived metabolites","volume":"12","author":"Verdugo-Meza","year":"2020","journal-title":"Nutrients"},{"key":"R38-20250602","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1136\/gutjnl-2020-323071","article-title":"Gut microbiota-derived metabolites as central regulators in metabolic disorders","volume":"70","author":"Agus","year":"2021","journal-title":"Gut"},{"key":"R39-20250602","doi-asserted-by":"crossref","first-page":"1179552218791173","DOI":"10.1177\/1179552218791173","article-title":"Plasma-free amino acid profiles in Crohn's disease: Relationship with the crohn disease activity index","volume":"11","author":"Chiba","year":"2018","journal-title":"Clin Med Insights Gastroenterol"},{"key":"R40-20250602","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1007\/s11033-020-05318-5","article-title":"Inflammatory bowel disease: Between genetics and microbiota","volume":"47","author":"Younis","year":"2020","journal-title":"Mol Biol Rep"},{"key":"R41-20250602","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nature10209","article-title":"Genetics and pathogenesis of inflammatory bowel disease","volume":"474","author":"Khor","year":"2011","journal-title":"Nature"},{"issue":"Suppl 1","key":"R42-20250602","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000504701","article-title":"Gender differences in inflammatory bowel disease","volume":"101","author":"Greuter","year":"2020","journal-title":"Digestion"},{"key":"R43-20250602","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1093\/ibd\/izac094","article-title":"Sex-related differences in inflammatory bowel diseases: The potential role of sex hormones","volume":"28","author":"Xu","year":"2022","journal-title":"Inflamm Bowel Dis"},{"key":"R44-20250602","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(20)31561-0","article-title":"Sex and gender: Modifiers of health, disease, and medicine","volume":"396","author":"Mauvais-Jarvis","year":"2020","journal-title":"Lancet"},{"key":"R45-20250602","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1006\/bbrc.1997.7683","article-title":"Estrogen receptor alpha and beta expression in upper gastrointestinal tract with regulation of trefoil factor family 2 mRNA levels in ovariectomized rats","volume":"240","author":"Campbell-Thompson","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"R46-20250602","doi-asserted-by":"crossref","first-page":"G621","DOI":"10.1152\/ajpgi.00274.2010","article-title":"Estrogen receptor-beta signaling modulates epithelial barrier function","volume":"300","author":"Looijer-van Langen","year":"2011","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"R47-20250602","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1038\/mi.2014.15","article-title":"Loss of estrogen-mediated immunoprotection underlies female gender bias in experimental Crohn's-like ileitis","volume":"7","author":"Goodman","year":"2014","journal-title":"Mucosal Immunol"},{"key":"R48-20250602","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1053\/j.gastro.2012.07.096","article-title":"Hormone therapy increases risk of ulcerative colitis but not Crohn's disease","volume":"143","author":"Khalili","year":"2012","journal-title":"Gastroenterology"},{"key":"R49-20250602","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1136\/gutjnl-2012-302362","article-title":"Oral contraceptives, reproductive factors and risk of inflammatory bowel disease","volume":"62","author":"Khalili","year":"2013","journal-title":"Gut"},{"key":"R50-20250602","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1097\/MEG.0000000000000915","article-title":"Exposure to oral contraceptives increases the risk for development of inflammatory bowel disease: A meta-analysis of case-controlled and cohort studies","volume":"29","author":"Ortizo","year":"2017","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R51-20250602","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/nri2815","article-title":"The X chromosome in immune functions: When a chromosome makes the difference","volume":"10","author":"Libert","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"R52-20250602","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s12016-017-8648-x","article-title":"Sexual dimorphism in innate immunity","volume":"56","author":"Jaillon","year":"2019","journal-title":"Clin Rev Allergy Immunol"},{"key":"R53-20250602","doi-asserted-by":"crossref","first-page":"928290","DOI":"10.1155\/2013\/928290","article-title":"Role of sex steroid hormones in bacterial-host interactions","volume":"2013","author":"Garc\u00eda-G\u00f3mez","year":"2013","journal-title":"Biomed Res Int"},{"key":"R54-20250602","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/trstmh\/tru167","article-title":"Sex-based differences in immune function and responses to vaccination","volume":"109","author":"Klein","year":"2015","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"R55-20250602","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1111\/apt.12963","article-title":"Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease","volume":"40","author":"Fedchuk","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"R56-20250602","first-page":"10","article-title":"The fatty liver index (FLI) 15 years later: A reappraisal","volume":"1","author":"Lonardo","year":"2021","journal-title":"Metab Target Organ Damage"},{"key":"R57-20250602","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.3390\/nu11123008","article-title":"Sex- and age-related differences in the contribution of ultrasound-measured visceral and subcutaneous abdominal fat to fatty liver index in overweight and obese Caucasian adults","volume":"11","author":"Leone","year":"2019","journal-title":"Nutrients"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000002859","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T19:05:00Z","timestamp":1748891100000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000002859"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,13]]},"references-count":56,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/cm9.0000000000002859","relation":{},"ISSN":["0366-6999","2542-5641"],"issn-type":[{"value":"0366-6999","type":"print"},{"value":"2542-5641","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,13]]},"assertion":[{"value":"2023-04-17","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}}]}}